Testing treatment for leaking mitral and tricuspid valves
Part of Heart & circulation clinical trials.
This trial studies people with atrial fibrillation and moderate-to-severe leakiness in the mitral and tricuspid valves in the heart. It likely aims to improve symptoms and heart function by better addressing how these valve leaks happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able and willing to sign informed consent for the study
- Be age 18 or older
- Have atrial fibrillation (an irregular heart rhythm)
- Have moderate or severe valve disease affecting the mitral and tricuspid valves
- Be able to get ultrasound heart pictures (echocardiogram) from several standard viewing angles
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This trial tests a treatment for people with atrial fibrillation who also have a leaky mitral valve. It aims to see if treating both conditions together can improve symptoms.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This trial tests a procedure that combines two treatments for people with atrial fibrillation and a leaky mitral valve that causes symptoms. The procedure aims to fix the valve leak and restore normal heart rhythm, which may improve quality of life and reduce symptoms.
This trial tests a device called the Pivot Bridge System to treat severe leakage of the tricuspid valve (the valve between the right upper and lower heart chambers). The goal is to see if it safely reduces symptoms like swelling and shortness of breath.
This trial uses safe, non-invasive tests to study people with moderate or severe tricuspid regurgitation (leaky valve on the right side of the heart). It aims to better understand the condition, which may lead to improved care in the future.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.